50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Walgreens maps out $1 billion in cost cuts as profit forecast underwhelms

Published 10/12/2023, 07:07 AM
Updated 10/12/2023, 12:07 PM
© Reuters. FILE PHOTO: Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo
WGBA34
-

(Reuters) -Walgreens Boots Alliance said on Thursday that it expected to cut at least $1 billion in costs in 2024 as part of its ongoing efforts, which include shutting unprofitable stores, after the pharmacy chain operator forecast financial year 2024 profit below Wall Street's expectations.

Shares of the company rose 5% in early trading, paring earlier premarket losses after it highlighted more cost-cutting measures, like using artificial intelligence to make its supply chain more efficient.

It is also lowering its capital expenditure by about $600 million. Its shares have fallen nearly 40% so far this year.

Walgreens has been contending with a steep drop in sales of COVID-19 products, persistently weak prescription drug demand, reported walkouts by its store staff and weak sales of its consumer health products due to high inflation.

Its adjusted profit of 67 cents per share in the fourth quarter also missed the LSEG estimate of 69 cents per share.

"Our performance this year has not reflected WBA's strong assets, brand legacy, or our commitment to our customers and patients," Interim CEO Ginger Graham said in a statement.

The company recorded a $6.8 billion pre-tax charge for opioid-related claims and litigation during the last financial year.

Walgreens had said in June it would close its stores at 150 locations in the United States. It also named Tim Wentworth, a former Cigna (NYSE:CI) executive, as permanent CEO on Tuesday.

The second-largest U.S. pharmacy chain operator, whose financial year ends in August, forecast an annual adjusted profit of $3.20 to $3.50 per share, compared to analysts' average estimate of $3.72 per share, according to LSEG data.

© Reuters. FILE PHOTO: Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo

In the fourth quarter, the company reported a 4.3% fall in U.S. retail sales and a 0.5% decline in total prescriptions filled, including vaccinations.

"Walgreens has lost customer share in areas like beauty and personal care. Some of this is because prices remain too high and are uncompetitive – something more and more shoppers won’t tolerate in the current environment," GlobalData Managing Director Neil Saunders said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.